欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/2192/001
药品名称Peditrace Novum
活性成分
    • Copper chloride dihydrate 107.4 µg/ml
    • Manganese chloride tetrahydrate 3.6 µg/ml
    • Potassium iodide 2.57 µg/ml
    • Sodium selenite 15.33 µg/ml
    • Zinc chloride 1.04 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Fresenius Kabi AB, Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Ireland (IE)
    • Estonia (EE)
    • Austria (AT)
    • Hungary (HU)
      Peditrace Novum concentrate for solution for infusion
    • France (FR)
    • Bulgaria (BG)
      Peditrace
    • Spain (ES)
    • Cyprus (CY)
      Peditrace Novum concentrate for solution for infusion
    • Portugal (PT)
    • Czechia (CZ)
      Peditrace Novum
    • Italy (IT)
    • Romania (RO)
      Peditrace Novum concentrate pentru soluţie perfuzabilă
    • Germany (DE)
      Peditrace Novum
    • Greece (GR)
    • Slovakia (SK)
    • Denmark (DK)
    • Norway (NO)
    • Slovenia (SI)
    • Belgium (BE)
    • Finland (FI)
      Peditrace Novum
    • Malta (MT)
      Peditrace Novum Concentrate for solution for infusion
    • Netherlands (NL)
    • Poland (PL)
      Peditrace Novum
    • Croatia (HR)
    • Luxembourg (LU)
    • Latvia (LV)
    • Iceland (IS)
    • Lithuania (LT)
      -
许可日期2023/04/18
最近更新日期2025/02/05
药物ATC编码
    • B05XA31 electrolytes in combination with other drugs
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase